“The apprehension with applying non IID mentioned ingredients is justified as it is actually impossible to evaluate if FDA would locate the ‘novel excipient’ Harmless for use in the drug product or service as there's no defined system for evaluation and approval of excipients. The FDA guidance on ‘Nonclinical https://wernerh283zrg9.wikimidpoint.com/user